EGFR Positive UK joins Cancer52 as our newest member.

In this State of Nation Report: No Cancer Too Rare, Cancer52 reviews policy developments since the 2024 General Election that will shape the next 10 years of cancer services. The report also reflects on what these developments means for our priorities for the UK Government and for making rare and less common cancers a priority in national policy.

Cancer52’s newest member, The Bardo Foundation is an international childhood cancer charity founded in memory of Bernardo “Bardo” Eggesbø.

Leiomyosarcoma Research UK has joined Cancer52.

The Rare Cancers Act 2026 will prioritise long overlooked aspects of research, and has the potential to transform outcomes for those affected by rare and less common cancers.

MOVE Against Cancer has joined Cancer52! Their mission is to support and empower everyone impacted by cancer to be more active because movement matters. They deliver evidence-based support through 5k Your Way community groups, tailored online programmes and accessible resources, improving wellbeing and supporting health outcomes during and after treatment. 

Cancer52 is pleased to welcome Lymphoma Out Loud  as our newest member! Lymphoma Out Loud  is a UK charity educating and raising awareness of lymphoma, one of the most common cancers in young people. They are a young charity with a rebel spirit, on a mission to disrupt lymphoma by educating, empowering, and amplifying patient voices through bold campaigns, education and lived experience. Find out more on their website - lymphomaoutloud.org

Cancer52 hosted The Big Cancer52 Conversation in Canary Wharf, London on 24th June 2025.   This was the sixth Big Cancer52 Conversation,...

Cancer52 is delighted to welcome The Get A-Head Charitable Trust as our newest member!

Cancer52 has submitted a response to the call for evidence to shape the National Cancer Plan for England